Filing Details
- Accession Number:
- 0001144204-15-071683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-18 16:03:44
- Reporting Period:
- 2015-12-16
- Filing Date:
- 2015-12-18
- Accepted Time:
- 2015-12-18 16:03:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293310 | Kalobios Pharmaceuticals Inc | KBIO | Pharmaceutical Preparations (2834) | 770557236 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1659573 | Edward Thomas Fernandez | C/O Kalobios Pharmaceuticals, Inc. 442 Littlefield Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-16 | 6,821 | $29.32 | 6,821 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Thomas Edward Fernandez acquired 6,821 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Thomas Edward Fernandez in the transaction was $199,991.72.